S74. EXPLORING PARTICIPANT-LEVEL TRAJECTORIES OF COGNITIVE PERFORMANCE AMONG PATIENTS WITH SCHIZOPHRENIA IN A MULTI-NATIONAL TRIAL

BACKGROUND: It remains unclear whether the lack of clinical trial success and drug approval for cognitive impairment associated with schizophrenia (CIAS) is due to compounds being ineffective, or whether trial methodology itself has been a limiting factor in successfully demonstrating the efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales: Granger, Kiri, Cotter, Jack, Baker, Elizabeth, Evenden, John, Barnett, Jennifer, Sand, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887555/
http://dx.doi.org/10.1093/schbul/sby018.861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5887555/
http://dx.doi.org/10.1093/schbul/sby018.861

Ejemplares similares